Mutation Status May Guide Treatment for HER2 Breast CancerMutation Status May Guide Treatment for HER2 Breast Cancer

It is likely that biomarkers will eventually help determine which therapy is best in HER2-positive disease. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news